Familial risk for esophageal cancer: An updated epidemiologic study from Sweden

被引:22
|
作者
Ji, Jianguang [1 ]
Hemminki, Kari
机构
[1] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
[2] German Canc Res Ctr DKFZ, Div Mol Genet Epidemiol, Heidelberg, Germany
关键词
D O I
10.1016/j.cgh.2006.03.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Familial risks for esophageal cancer are not well known, especially for specific histologic types. Methods: We used the nationwide Swedish Family-Cancer Database to examine familial risks for esophageal cancer in offspring. Standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) were used to calculate the risk. Age standardized incidence rates for specific histology types of esophageal cancer were availiable from Swedish Cancer Registry. Results: The incidence of male squamous cell carcinoma (SCC) reached its peak rate in 1985 and decreased afterwards. The incidence of adenocarcinoma exceeded that of SCC in 2000 among men. The SIR for offspring esophageal cancer was significantly increased when a parent presented with esophageal cancer (SIR, 2.60). The SIRs for adenocarcinoma were 4.05 and 3.52 when a parent was diagnosed with SCC and any esophageal cancer, respectively; from maternal probands the SIRs were 10.47 and 7.74, respectively. The familial SIR was above unity but not significant for SCC. For associations with other cancer sites, SCC showed a significantly increased risk when a sibling had lung cancer (SIR, 2.52). Conclusions: The present study showed that adenocarcinoma became the major histologic type of esophageal cancer in Swedish men around 2000. For the first time we could show that familial risks of esophageal adenocarcinoma were increased when parents presented with esophageal cancer (particularly SCC). The high risk for adenocarcinoma in such families might be due to heritable effects. However, because of the limited number of familial cases, the results should be interpreted with caution.
引用
收藏
页码:840 / 845
页数:6
相关论文
共 50 条
  • [21] Epidemiologic trends for esophageal cancer
    Sevensma, E. T.
    Kort, E. J.
    Fitzgerald, T. L.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 101 - 101
  • [22] EPIDEMIOLOGIC ASPECTS OF ESOPHAGEAL CANCER
    MUNOZ, N
    ENDOSCOPY, 1993, 25 (09) : 609 - 612
  • [23] RHABDOMYOSARCOMA IN CHILDREN - EPIDEMIOLOGIC STUDY AND IDENTIFICATION OF A FAMILIAL CANCER SYNDROME
    LI, FP
    FRAUMENI, JF
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1969, 43 (06) : 1365 - &
  • [24] Phytoestrogens and risk of prostate cancer: an updated meta-analysis of epidemiologic studies
    Zhang, Qiang
    Feng, Hongliang
    Qluwakemi, Bakare
    Wang, Jiaqi
    Yao, Songpo
    Cheng, Guangdong
    Xu, Hui
    Qiu, Hongbin
    Zhu, Liling
    Yuan, Mingxia
    INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2017, 68 (01) : 28 - 42
  • [25] Familial risk of vasospastic angina: a nationwide family study in Sweden
    Ricci, Fabrizio
    Banihashemi, Behzad
    Pirouzifard, Mirnabi
    Sundquist, Jan
    Sundquist, Kristina
    Sutton, Richard
    Fedorowski, Artur
    Zoller, Bengt
    OPEN HEART, 2023, 10 (02):
  • [26] Esophageal Cancer: An Updated Review
    DiSiena, Michael
    Perelman, Alexander
    Birk, John
    Rezaizadeh, Houman
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (03) : 161 - 168
  • [27] AN EPIDEMIOLOGIC-STUDY ON OCCUPATION AND CANCER RISK
    KATO, I
    TOMINAGA, S
    IKARI, A
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1990, 20 (02) : 121 - 127
  • [28] Familial prostate cancer in Sweden - A nationwide register cohort study
    Gronberg, H
    Damber, L
    Damber, JE
    CANCER, 1996, 77 (01) : 138 - 143
  • [29] Familial risk for soft tissue tumors: a nation-wide epidemiological study from Sweden
    Ji, Jianguang
    Eng, Charis
    Hemminki, Kari
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (05) : 617 - 624
  • [30] Familial risk for soft tissue tumors: a nation-wide epidemiological study from Sweden
    Jianguang Ji
    Charis Eng
    Kari Hemminki
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 617 - 624